about
Generalized morphea and primary biliary cirrhosis coexisting in a male patientA rare association of localized scleroderma type morphea, vitiligo, autoimmune hypothyroidism, pneumonitis, autoimmune thrombocytopenic purpura and central nervous system vasculitis. Case reportAntiphospholipid antibodies in localized scleroderma: the potential role of screening tests for the detection of antiphospholipid syndrome.Extracorporeal photochemotherapy for generalized deep morphea.Cutaneous Connective Tissue Diseases: Epidemiology, Diagnosis, and Treatment.Segmental vitiligo with segmental morphea: An autoimmune link?A case of radiation-induced generalized morphea with prominent mucin deposition and tenderness.Emergence of T cells that recognize nonpolymorphic antigens during graft-versus- host diseaseAbsence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.Pediatric scleroderma: systemic or localized formsPeripheral blood cytokine and chemokine profiles in juvenile localized scleroderma: T-helper cell-associated cytokine profiles.Interleukin-17A and interleukin-23 in morphea.Evaluation of serum concentrations of the selected cytokines in patients with localized scleroderma.Cytokine profiles in localized scleroderma and relationship to clinical features.A rare case of hidebound disease with dental implications.Scleroderma and dentistry: Two case reports.Localized scleroderma in children: clinical, diagnostic and therapeutic aspects.Localized scleroderma.Overlapping gene expression profiles indicative of antigen processing and the interferon pathway characterize inflammatory fibrotic skin diseases.Interleukin-17 in human inflammatory diseases.Delay in Diagnosis of Congenital Linear Scleroderma until Adulthood.Morphea and Eosinophilic Fasciitis: An Update.The efficacy of methotrexate in the treatment of en coup de sabre (linear morphea subtype).Effects of UVA1 Phototherapy on Expression of Human Endogenous Retroviral Sequence (HERV)-K10 gag in Morphea: A Preliminary Study.Morphoea with prominent plasma cell endoneuritis.Concomitant appearance of morphea and vitiligo in a patient with autoimmune thyroiditis.Simultaneous occurrence of scleroderma, neuromyotonia, and inflammatory myopathy: Evidence of common immunological etiology.Th1- and Th17-polarized immune infiltrates in eosinophilic fasciitis-A potential marker for histopathologic distinction from morphea.European Dermatology Forum S1-guideline on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: localized scleroderma, systemic sclerosis and overlap syndromes.Oxidative stress parameters in localized scleroderma patients.Detection of autoimmune antibodies in localized scleroderma by synthetic oligonucleotide antigens.Selective deletion of PPARβ/δ in fibroblasts causes dermal fibrosis by attenuated LRG1 expression.Clinical and laboratory features of systemic sclerosis complicated with localized scleroderma.
P2860
Q28268456-70B1E7E8-A8C6-4509-B8FB-505896C84CE6Q33404912-18D8CF5D-5431-4B61-AE0A-F553D7E16B0DQ33416909-50226DF7-565A-4F52-AE5D-5A9A0A99B098Q33821569-A1A13025-3990-4C0D-BC56-EE1CB20E285FQ34466996-8DE38EF6-5926-4B83-B109-A535D9841AD5Q34616854-8F0D0EC7-AA38-4B0B-8871-16FF35B1F0BDQ35608941-2F95A541-E91F-40D9-A4FF-FCF261F38B57Q36058558-1D2B0AB9-AC7E-401D-A9BE-A96A5C30D8E2Q36141721-C4DEDC5E-5EF7-4117-8C3C-DB795A48FD65Q36282971-83BD0AF2-DF25-4B29-9006-DD41EB38A0B3Q36307704-2BA353A5-5635-4757-A8DC-CA7509AA0294Q36524875-4C996DCE-D59C-48C8-A4E2-754A5243DC5FQ36690499-3639C0D8-97ED-4C4E-A7C1-2FA72429294BQ36784652-2C20AB48-5D47-463C-990E-0AA5EC87ED85Q37222249-93B476A5-8F25-4149-BC29-7935044E5E06Q37364181-D2131190-19ED-4CD0-9E4A-6FC679D256D0Q37510670-2C04757A-6E7F-4146-BF51-9803A9801667Q38022272-1296ABF4-5EFF-4974-87D1-899E5C8295FDQ38175063-DA0D0F42-C461-4E2B-8A7E-D9361DC76981Q38254127-5D731C93-510D-4D43-8CCE-60B44865D9CFQ38379858-5A55D550-339D-4A87-B114-8BC2CFC81D4DQ38902145-A0D2EB3A-2559-4F31-A585-32B3442AA97EQ39366166-B5CA69F8-849E-4FE7-9007-CD1219395A12Q40355305-6A8C743C-8126-4FD8-9A51-7829DD616B3BQ40385716-937847E7-8B1D-42C2-9194-7D86500029AFQ40971738-C52AF2A8-C5F4-4BEA-8A79-69018CA13C2DQ41823075-A2F77A86-EFAF-438A-9E4C-82C4332642EFQ48298768-DD764A94-80C2-4A32-A809-75FB0AEEF437Q49072027-4DA0C147-B353-416A-8CB9-E350C2F26EB7Q51534954-1C5A329E-9324-4EDB-8749-6B5B092428D8Q52594150-4F65AECF-4B65-4B56-8ADE-8EBE940AC7C7Q52605977-A3BA3A6C-A53A-4ECB-B987-1F392DFD511BQ53645962-DB47A624-FED9-4985-BC39-E1FCEFFA6E59
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Localized scleroderma is an autoimmune disorder.
@ast
Localized scleroderma is an autoimmune disorder.
@en
Localized scleroderma is an autoimmune disorder.
@nl
type
label
Localized scleroderma is an autoimmune disorder.
@ast
Localized scleroderma is an autoimmune disorder.
@en
Localized scleroderma is an autoimmune disorder.
@nl
prefLabel
Localized scleroderma is an autoimmune disorder.
@ast
Localized scleroderma is an autoimmune disorder.
@en
Localized scleroderma is an autoimmune disorder.
@nl
P356
P1433
P1476
Localized scleroderma is an autoimmune disorder.
@en
P2093
P304
P356
10.1093/RHEUMATOLOGY/KEH487
P577
2004-11-23T00:00:00Z